Viral Load Suppression in People Living with HIV Before and During the COVID-19 Pandemic in Brooklyn, New York.
CD4
COVID-19
HIV
New York
PWH
Viral load
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
05 Jun 2024
05 Jun 2024
Historique:
accepted:
15
05
2024
medline:
5
6
2024
pubmed:
5
6
2024
entrez:
5
6
2024
Statut:
aheadofprint
Résumé
Consistent care is crucial for the health maintenance of people living with human immunodeficiency virus (HIV) (PWH). The coronavirus 2019 (COVID-19) epidemic disrupted patient care in New York City (NYC), yet few studies investigated the association between COVID-19 and viral load suppression in PWH in NYC. This study aims to assess how the COVID-19 pandemic impacted HIV viral load and CD4 + T-cell counts in PWH. Medical records of 1130 adult HIV patients who visited the Special Treatment and Research Health Center in Brooklyn, NY, between January 2019 and May 2023 were compared across three timeframes (pre-pandemic, January 1, 2019 to December 31, 2019; first pandemic phase, March 19, 2020 to December 31, 2020; and second pandemic phase, January 1, 2021 to May 11, 2023). Demographic and clinical variables (e.g. viral load and CD4 + T cell count) were assessed. About 40% of patients did not have routine laboratory monitoring during the first pandemic phase compared with pre-pandemic. The mean HIV viral load was higher during the second pandemic phase compared with pre-pandemic (p = 0.009). The percentages of patients with undetectable HIV viral load and numbers (mm
Identifiants
pubmed: 38836987
doi: 10.1007/s10461-024-04385-0
pii: 10.1007/s10461-024-04385-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Full report – in Danger: Unaids global aids update 2022: UNAIDS. 2022. Retrieved 1/1/2024 from https://www.unaids.org/en/resources/documents/2022/in-danger-global-aids-update
Lucas S, Nelson AM. HIV and the spectrum of human disease. J Pathol. 2015;235(2):229–41. https://doi.org/10.1002/path.4449 .
doi: 10.1002/path.4449
pubmed: 25251832
Fanales-Belasio E, Raimondo M, Suligoi B, Buttò S. HIV virology and pathogenetic mechanisms of infection: a brief overview. Ann Ist Super Sanita. 2010;46(1):5–14. https://doi.org/10.4415/ann_10_01_02 .
doi: 10.4415/ann_10_01_02
pubmed: 20348614
Nies-Kraske E, Schacker TW, Condoluci D, Orenstein J, Brenchley J, Fox C, Daucher M, Dewar R, Urban E, Hill B, Guenaga J, Hoover S, Maldarelli F, Hallahan CW, Horn J, Kottilil S, Chun TW, Folino M, Palmer S, Dybul M. Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. J Infect Dis. 2009;199(11):1648–56. https://doi.org/10.1086/598980 .
doi: 10.1086/598980
pubmed: 19432547
Hoenigl M, Chaillon A, Moore DJ, Morris SR, Mehta SR, Gianella S, Amico KR, Little SJ. Rapid HIV viral load suppression in those initiating antiretroviral therapy at first visit after HIV diagnosis. Sci Rep. 2016;6:32947. https://doi.org/10.1038/srep32947 .
doi: 10.1038/srep32947
pubmed: 27597312
pmcid: 5011704
HIV/AIDS Annual Surveillance Statistics: New York City Department of Health and Mental Hygiene. Retrieved 1/1/2024 from https://www.nyc.gov/site/doh/data/data-sets/hiv-aids-surveillance-and-epidemiology-reports.page (2022)
HIV/AIDS Statistics in New York State: New York State Department of Health. 2022. Retrieved 1/1/24 from https://www.health.ny.gov/diseases/aids/general/statistics/
Conan N, Badawi M, Chihana ML, Wanjala S, Kingwara L, Mambula C, Ngugi C, Okomo G, Opollo V, Salumu L, Nesbitt R, Szumilin E, Huerga H. Two-fold increase in the HIV viral load suppression rate along with decreased incidence over six years in Ndhiwa sub-county. Kenya Trop Med Int Health. 2021;26(12):1609–15. https://doi.org/10.1111/tmi.13688 .
doi: 10.1111/tmi.13688
pubmed: 34637172
HIV. NYC Health. 2024. Retrieved 4/2/2024 from https://www.nyc.gov/site/doh/health/health-topics/aids-hiv.page
New HIV Diagnoses Fall to Historic Low As New York City Nears Goal to End the Epidemic, Mayor De Blasio to Participate in “World Aids Day 2020” Virtual Event. NYC Health. 2020. Retrieved April 2, 2024 from https://www.nyc.gov/site/doh/about/press/pr2020/new-hiv-diagnoses-fall-to-historic-low.page
2025 AIDS Targets: UNAIDS. 2021. Retrieved April 2, 2024 from https://www.unaids.org/sites/default/files/2025-AIDS-Targets_en.pdf
Coronavirus disease (COVID-19) pandemic: World Health Organization. Retrieved 1/1/24 from https://www.who.int/europe/emergencies/situations/covid-19 (2023)
Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review. J Intern Med. 2021;289(4):450–62. https://doi.org/10.1111/joim.13184 .
doi: 10.1111/joim.13184
pubmed: 33020988
Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-specific immune response and the pathogenesis of COVID-19. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23031716 .
doi: 10.3390/ijms23031716
pubmed: 36499583
pmcid: 9699257
Sessa C, Cortes J, Conte P, Cardoso F, Choueiri T, Dummer R, Lorusso P, Ottmann O, Ryll B, Mok T, Tempero M, Comis S, Oliva C, Peters S, Tabernero J. The impact of COVID-19 on cancer care and oncology clinical research: an experts’ perspective. ESMO Open. 2022;7(1): 100339. https://doi.org/10.1016/j.esmoop.2021.100339 .
doi: 10.1016/j.esmoop.2021.100339
pubmed: 34953404
VanBenschoten H, Kuganantham H, Larsson EC, Endler M, Thorson A, Gemzell-Danielsson K, Hanson C, Ganatra B, Ali M, Cleeve A. Impact of the COVID-19 pandemic on access to and utilisation of services for sexual and reproductive health: a scoping review. BMJ Glob Health. 2022. https://doi.org/10.1136/bmjgh-2022-009594 .
doi: 10.1136/bmjgh-2022-009594
pubmed: 36202429
Spinelli MA, Jones BLH, Gandhi M. COVID-19 outcomes and risk factors among people living with HIV. Curr HIV/AIDS Rep. 2022;19(5):425–32. https://doi.org/10.1007/s11904-022-00618-w .
doi: 10.1007/s11904-022-00618-w
pubmed: 35930187
pmcid: 9362624
Brown LB, Spinelli MA, Gandhi M. The interplay between HIV and COVID-19: summary of the data and responses to date. Curr Opin HIV AIDS. 2021;16(1):63–73. https://doi.org/10.1097/coh.0000000000000659 .
doi: 10.1097/coh.0000000000000659
pubmed: 33186229
pmcid: 7735216
Latini A, Donà MG, Giuliani M, Pontone M, Ancona C, Foracappa S, Morrone A, Zaccarelli M. Short communication: HIV viral load trends during the coronavirus disease 2019 pandemic in a reference center for HIV in Rome. Italy AIDS Res Hum Retroviruses. 2021;37(8):624–6. https://doi.org/10.1089/aid.2021.0044 .
doi: 10.1089/aid.2021.0044
pubmed: 33966477
Gatechompol S, Avihingsanon A, Putcharoen O, Ruxrungtham K, Kuritzkes DR. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Res Ther. 2021;18(1):28. https://doi.org/10.1186/s12981-021-00335-1 .
doi: 10.1186/s12981-021-00335-1
pubmed: 33952300
pmcid: 8097669
Hanson HA, Kim E, Badowski ME. A systematic review: impact of SARS-CoV-2 infection on morbidity, mortality, and viral suppression in patients living with HIV. SN Compr Clin Med. 2023;5(1):144. https://doi.org/10.1007/s42399-023-01480-6 .
doi: 10.1007/s42399-023-01480-6
pubmed: 37214621
pmcid: 10183680
Fernàndez-López L, Simões D, Casabona J. Impact of the COVID-19 pandemic on community-based testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Eur J Public Health. 2023;33(3):528–35. https://doi.org/10.1093/eurpub/ckad010 .
doi: 10.1093/eurpub/ckad010
pubmed: 36928984
pmcid: 10234647
Mirzaei H, Moradi Y, Abbaszadeh S, Nasiri N, Mehmandoost S, Khezri M, Tavakoli F, Sharifi H. The impact of COVID-19 on disruptions of HIV-related services: a rapid review. Med J Islam Repub Iran. 2022;36:98. https://doi.org/10.47176/mjiri.36.98 .
doi: 10.47176/mjiri.36.98
pubmed: 36419948
pmcid: 9588155
Hong C, Queiroz A, Hoskin J. The impact of the COVID-19 pandemic on mental health, associated factors and coping strategies in people living with HIV: a scoping review. J Int AIDS Soc. 2023;26(3): e26060. https://doi.org/10.1002/jia2.26060 .
doi: 10.1002/jia2.26060
pubmed: 36912238
pmcid: 10009802
Vicente BM, Neto JV, Quaresma M, Vasconcelos JS, Espíndola Bauchiunas R, Dos Santos ECM, Picone CM, Ibrahim KY, Avelino-Silva VI, de Melo CM, Segurado AC, Lima Ribeiro SM. Covid-19 social distancing, lifestyle and health outcomes among persons living with HIV (PLWH): a web-based survey. AIDS Behav. 2022;26(12):4144–55. https://doi.org/10.1007/s10461-022-03740-3 .
doi: 10.1007/s10461-022-03740-3
pubmed: 35699860
pmcid: 9194884
Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, Ross M, Forest S, Goldstein YD, Ajaimy M, Liriano-Ward L, Pynadath C, Loarte-Campos P, Nandigam PB, Graham J, Le M, Rocca J, Kinkhabwala M. Covid-19 and kidney transplantation. N Engl J Med. 2020;382(25):2475–7. https://doi.org/10.1056/NEJMc2011117 .
doi: 10.1056/NEJMc2011117
pubmed: 32329975
Suwanwongse K, Shabarek N. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city. J Med Virol. 2020;92(11):2387–9. https://doi.org/10.1002/jmv.26077 .
doi: 10.1002/jmv.26077
pubmed: 32462663
pmcid: 7283854
Cordes J, Castro MC. Spatial analysis of COVID-19 clusters and contextual factors in New York City. Spat Spatiotemporal Epidemiol. 2020;34: 100355. https://doi.org/10.1016/j.sste.2020.100355 .
doi: 10.1016/j.sste.2020.100355
pubmed: 32807400
pmcid: 7306208
Klein M. Cuomo’s coronavirus-only hospital became deadly amid shortages of meds, PPE: insiders. 2020. New York Post. Retrieved 1/1/24 from https://nypost.com/2020/07/25/cuomos-covid-only-hospital-ran-short-on-ppe-meds/
End of the Federal COVID-19 Public Health Emergency (PHE) Declaration: Centers for Disease Control and Prevention. Retrieved 1/1/24 from https://archive.cdc.gov/#/details?url=https://www.cdc.gov/coronavirus/2019-ncov/your-health/end-of-phe.html (2023).
Broyles LN, Luo R, Boeras D, Vojnov L. The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review. Lancet. 2023;402(10400):464–71. https://doi.org/10.1016/s0140-6736(23)00877-2 .
doi: 10.1016/s0140-6736(23)00877-2
pubmed: 37490935
pmcid: 10415671
Songo J, Whitehead HS, Nichols BE, Makwaya A, Njala J, Phiri S, Hoffman RM, Dovel K, Phiri K, van Oosterhout JJ. Provider-led community antiretroviral therapy distribution in Malawi: retrospective cohort study of retention, viral load suppression and costs. PLOS Glob Public Health. 2023;3(9): e0002081. https://doi.org/10.1371/journal.pgph.0002081 .
doi: 10.1371/journal.pgph.0002081
pubmed: 37768889
pmcid: 10538660
Battistini Garcia SA, & Guzman N. Acquired Immune Deficiency Syndrome CD4+ Count. In StatPearls. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC. 2023. Retrieved 1/1/24 from https://www.ncbi.nlm.nih.gov/books/NBK513289/
CDC Museum COVID-19 Timeline: Centers for Disease Control and Prevention. 2023. Retrieved 1/1/24 from https://www.cdc.gov/museum/timeline/covid19.html#:~:text=March%2011%2C%202020,declares%20COVID%2D19%20a%20pandemic
Governor Cuomo Signs Executive Order Closing Schools Statewide for Two Weeks. New York State. 2020. Retrieved 1/1/24 from https://www.governor.ny.gov/news/governor-cuomo-signs-executive-order-closing-schools-statewide-two-weeks
Monitoring Selected National HIV Prevention and Care Objectives By Using HIV Surveillance Data United States and 6 Dependent Areas, 2019: Technical Notes. Centers for Disease Control and Prevention. 2023. Retrieved 1/1/24 from https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-26-no-2/content/technical-notes.html#:~:text=HIV%20infection%2C%20stage%203%20(AIDS,of%20total%20lymphocytes%20of%20%3C14
Hoover KW, Zhu W, Gant ZC, Delaney KP, Wiener J, Carnes N, Thomas D, Weiser J, Huang YA, Cheever LW, Kourtis AP. HIV services and outcomes during the COVID-19 Pandemic - United States, 2019–2021. MMWR Morb Mortal Wkly Rep. 2022;71(48):1505–10. https://doi.org/10.15585/mmwr.mm7148a1 .
doi: 10.15585/mmwr.mm7148a1
pubmed: 36454696
pmcid: 9721149
Kalua T, Egger M, Jahn A, Chimpandule T, Kolola R, Anderegg N. HIV suppression was maintained during the COVID-19 pandemic in Malawi: a program-level cohort study. J Clin Epidemiol. 2022;150:116–25. https://doi.org/10.1016/j.jclinepi.2022.06.019 .
doi: 10.1016/j.jclinepi.2022.06.019
pubmed: 35788400
pmcid: 9249434
Wagner Z, Mukasa B, Nakakande J, Stecher C, Saya U, Linnemayr S. Impact of the COVID-19 pandemic on use of HIV care, antiretroviral therapy adherence, and viral suppression: an observational cohort study from Uganda. J Acquir Immune Defic Syndr. 2021;88(5):448–56. https://doi.org/10.1097/qai.0000000000002811 .
doi: 10.1097/qai.0000000000002811
pubmed: 34757973
pmcid: 8575089
Shah GH, Etheredge GD, Smallwood SW, Maluantesa L, Waterfield KC, Ikhile O, Ditekemena J, Engetele E, Ayangunna E, Mulenga A, Bossiky B. HIV viral load suppression before and after COVID-19 in Kinshasa and Haut Katanga, Democratic Republic of the Congo. South Afr J HIV Med. 2022;23(1):1421. https://doi.org/10.4102/sajhivmed.v23i1.1421 .
doi: 10.4102/sajhivmed.v23i1.1421
pubmed: 36353191
pmcid: 9634654
Carbonero-Lechuga P, Castrodeza-Sanz J, Sanz-Muñoz I, Marqués-Sánchez P, Eiros JM, Dueñas-Gutiérrez C, Prada-García C. Impact of COVID-19 on adherence to treatment in patients with HIV. Healthcare (Basel). 2023. https://doi.org/10.3390/healthcare11091299 .
doi: 10.3390/healthcare11091299
pubmed: 37174841
Izudi J, Kiragga AN, Kalyesubula P, Okoboi S, Castelnuovo B. Effect of the COVID-19 pandemic restrictions on outcomes of HIV care among adults in Uganda. Medicine (Baltimore). 2022;101(36): e30282. https://doi.org/10.1097/md.0000000000030282 .
doi: 10.1097/md.0000000000030282
pubmed: 36086721
Izzo I, Carriero C, Gardini G, Fumarola B, Chiari E, Castelli F, Quiros-Roldan E. Impact of COVID-19 pandemic on HIV viremia: a single-center cohort study in northern Italy. AIDS Res Ther. 2021;18(1):31. https://doi.org/10.1186/s12981-021-00355-x .
doi: 10.1186/s12981-021-00355-x
pubmed: 34088307
pmcid: 8177258
Kessel B, Heinsohn T, Ott JJ, Wolff J, Hassenstein MJ, Lange B. Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV/AIDS and malaria-A systematic review. PLOS Glob Public Health. 2023;3(5): e0001018. https://doi.org/10.1371/journal.pgph.0001018 .
doi: 10.1371/journal.pgph.0001018
pubmed: 37126484
pmcid: 10150989
Viguerie A, Song R, Johnson AS, Lyles CM, Hernandez A, Farnham PG. Isolating the effect of COVID-19-related disruptions on HIV diagnoses in the United States in 2020. J Acquir Immune Defic Syndr. 2023;92(4):293–9. https://doi.org/10.1097/qai.0000000000003140 .
doi: 10.1097/qai.0000000000003140
pubmed: 36515707
pmcid: 10111242
Liang C, Suen SC, Nguyen A, Moucheraud C, Hsu L, Holloway IW, Charlebois ED, Steward WT. Impact of COVID-19 response on the HIV epidemic in men who have sex with men in San Francisco county: the importance of rapid return to normalcy. J Acquir Immune Defic Syndr. 2023;92(5):370–7. https://doi.org/10.1097/qai.0000000000003156 .
doi: 10.1097/qai.0000000000003156
pubmed: 36728397
Spinelli MA, Hickey MD, Glidden DV, Nguyen JQ, Oskarsson JJ, Havlir D, Gandhi M. Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19. AIDS. 2020;34(15):2328–31. https://doi.org/10.1097/qad.0000000000002677 .
doi: 10.1097/qad.0000000000002677
pubmed: 32910069
Wilson TE, Barrón Y, Cohen M, Richardson J, Greenblatt R, Sacks HS, Young M. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002;34(4):529–34. https://doi.org/10.1086/338397 .
doi: 10.1086/338397
pubmed: 11797182
Wilson TE, Gore ME, Greenblatt R, Cohen M, Minkoff H, Silver S, Robison E, Levine A, Gange SJ. Changes in sexual behavior among HIV-infected women after initiation of HAART. Am J Public Health. 2004;94(7):1141–6. https://doi.org/10.2105/ajph.94.7.1141 .
doi: 10.2105/ajph.94.7.1141
pubmed: 15226134
pmcid: 1448412
Diamond C, Richardson JL, Milam J, Stoyanoff S, McCutchan JA, Kemper C, Larsen RA, Hollander H, Weismuller P, Bolan R. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. J Acquir Immune Defic Syndr. 2005;39(2):211–8.
pubmed: 15905739
Holstad MM, Diiorio C, McCarty F. Adherence, sexual risk, and viral load in HIV-infected women prescribed antiretroviral therapy. AIDS Patient Care STDS. 2011;25(7):431–8. https://doi.org/10.1089/apc.2010.0331 .
doi: 10.1089/apc.2010.0331
pubmed: 21663541
pmcid: 3125575
Yaya I, Saka B, Landoh DE, Patchali PM, Makawa MS, Senanou S, Idrissou D, Lamboni B, Pitche P. Sexual risk behavior among people living with HIV and AIDS on antiretroviral therapy at the regional hospital of Sokodé. Togo BMC Public Health. 2014;14:636. https://doi.org/10.1186/1471-2458-14-636 .
doi: 10.1186/1471-2458-14-636
pubmed: 24952380
Gleason N, Banik S, Braverman J, Coleman E. The impact of the COVID-19 pandemic on sexual behaviors: findings from a national survey in the United States. J Sex Med. 2021;18(11):1851–62. https://doi.org/10.1016/j.jsxm.2021.08.008 .
doi: 10.1016/j.jsxm.2021.08.008
pubmed: 34535369
pmcid: 8417519
Abedinzadeh M, Vahidi S, Rahavian A, Lojje H, Abouei S. Effect of COVID-19 on the sexual activity of men. Am J Mens Health. 2023;17(4):15579883231193912. https://doi.org/10.1177/15579883231193913 .
doi: 10.1177/15579883231193913
pubmed: 37599378
pmcid: 10467192
Masoudi M, Maasoumi R, Bragazzi NL. Effects of the COVID-19 pandemic on sexual functioning and activity: a systematic review and meta-analysis. BMC Public Health. 2022;22(1):189. https://doi.org/10.1186/s12889-021-12390-4 .
doi: 10.1186/s12889-021-12390-4
pubmed: 35086497
pmcid: 8794736
Wang S, Yang J, Niu D, Hou Y, Fei L, Zhao H, Chen F, Lv F. Change of sexual behavior among men who have sex with men before, during and after COVID-19 pandemic in China: a cross-sectional study. BMC Infect Dis. 2023;23(1):527. https://doi.org/10.1186/s12879-023-08488-2 .
doi: 10.1186/s12879-023-08488-2
pubmed: 37563554
pmcid: 10416525
Bessong PO, Mavhandu-Ramarumo LG. Moving towards the global HIV 95% viral suppression target. Lancet HIV. 2021;8(12):e731–2. https://doi.org/10.1016/s2352-3018(21)00273-3 .
doi: 10.1016/s2352-3018(21)00273-3
pubmed: 34856177